Jung Cassie
SEC CIK 1960154 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | SVP, Ops | 206.8K | — | $975.8K | 16 | 2023-03-09 | 2026-09-03 |
Most active insiders at AQST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| 2 | Jung Cassie | COO | — | $664.6K |
| 3 | Boyd Peter E. | See Remarks | — | $257.3K |
| 4 | TOTH A ERNEST JR | CFO | — | $242.9K |
| 5 | BRAENDER LORI J | Corp. Sec | — | $167.2K |
| 6 | Kraus Carl N | Chief Medical Off | — | $141.9K |
| 7 | Krop Julie | Dir | — | $125.4K |
| 8 | Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| 9 | Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| 10 | Zalewski Thomas A. | CLO | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-08 16:06 | 2026-09-03 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | X - OptEx | $0.96 | +4,587 | 206.8K | +2% | +$4,404 |
| 2026-05-07 17:32 | 2026-05-05 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | F - Tax | $4.18 | -72.7K | 202.2K | -26% | -$304.0K | |
| D | 2026-03-11 | 2026-03-09 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | A - Grant | $0.00 | +80.0K | 320.8K | +33% | $0 |
| D | 2026-03-11 | 2026-03-10 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | S - Sale | $4.17 | -45.8K | 275.0K | -14% | -$190.9K |
| D | 2025-10-17 | 2025-10-15 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | S - Sale+OE | $7.01 | -67.6K | 240.8K | -22% | -$473.7K |
| D | 2025-10-17 | 2025-10-15 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | M - OptEx | $3.10 | +25.0K | 308.3K | +9% | +$77.5K |
| DM | 2025-09-08 | 2025-09-04 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | M - OptEx | $1.93 | +50.0K | 345.5K | +17% | +$96.5K |
| D | 2025-09-08 | 2025-09-04 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | S - Sale+OE | $5.00 | -62.2K | 283.3K | -18% | -$310.9K |
| D | 2025-03-11 | 2025-03-07 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | A - Grant | $0.00 | +80.0K | 313.1K | +34% | $0 |
| DM | 2025-03-11 | 2025-03-07+ | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | F - Tax | $2.64 | -17.5K | 295.5K | -6% | -$46.2K |
| I | 2024-11-27 | 2024-11-26 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | S - Sale | $4.87 | -44 | 0 | -100% | -$214.28 |
| A | 2024-10-02 | 2024-03-09 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | SVP, Ops | F - Tax | $4.88 | -14.1K | 233.1K | -6% | -$68.9K |
| M | 2024-03-12 | 2024-03-09+ | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | SVP, Ops | F - Tax | $4.88 | -9,432 | 238.9K | -4% | -$46.0K |
| D | 2024-03-11 | 2023-03-10 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | SVP, Ops | F - Tax | $0.00 | -1,365 | 145.9K | -0.9% | $0 |
| D | 2024-03-11 | 2024-03-07 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | SVP, Ops | A - Grant | $0.00 | +101.2K | 247.2K | +69% | $0 |
| 2023-03-09 | 2023-03-09 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | SVP, Ops | A - Grant | $0.00 | +110.0K | 146.7K | +299% | $0 |
Purchase Sale Sale after option exercise All abbreviations